Skip to main content
. 2009 Apr;73(2):117–124.

Table I.

Details of infection with Bovine viral diarrhea virus (BVDV), vaccination against several bovine viruses, and antibody responses in persistently infected (PI) cattle commingled for 11 mo

BVDV antibody; titerb on day 0/day 342 of commingling
Dates of vaccination and initial diagnosis (2005) Animal no. BVDV subtype Vaccine typea 1a 1b 2a
8/26, 8/26 8232c 2a MLV 128 32 512
7/25, 9/14 8233 2a MLV 4/256 4/128 0/0
5/30, 7/30 8234 1b MLV 0/0 0/0 0/0
7/25, 9/20 8235 1a Killed 0/128 0/8 0/64
10/4, 10/3 8236 1a MLV 2048/2048 512/128 1024/512
5/25, 7/25 8237 1b Killed 0/16 0/4 0/64
10/17, 10/17 8238 1b MLV 1024/256 4/0 256/64
8/18, 8/18 8239 1b MLV 2048/1024 128/128 256/64
10/4, 10/3 8240 1a MLV 1024/256 32/32 256/32
9/22, 9/22 8241 1a MLV 1024/512 4/4 64/8
8/26, 8/26 8242c 2a MLV 512 32 64
10/11, 9/19 8243c 2a MLV 0 0 0

MLV — modified live virus.

a

The vaccine contained MLV or killed BVDV-1a Singer and BVDV-2a 5912, among other components.

b

Reciprocal of the end-point titer in the viral neutralization test (VNT) in the day 0 and day 342 collections; zero indicates a titer of < 1:4.

c

Died with mucosal signs and lesions on May 6 (study day 137), April 18 (day 119), and January 2 (day 13), 2006, respectively.